THE ROLE OF AT-HOME CONSUMER DIAGNOSTICS INCREASES Saliva-based home pregnancy test arrives at Australian pharmacies
With
Dr Anita Sharma, GP
Platinum Medical Centre,
Brisbane
Michael Cima, CEO & Director
CC Supplies,
Byron Bay
SEGMENT
Filmed in Brisbane | March 2026
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
According to Dr Anita Sharma, a Brisbane based GP at Platinum Medical Centre, traditional medical testing still plays an important role. Situations such as unclear symptoms, early-stage conditions with low detectable markers, or practical limitations—like insufficient saliva samples—may require confirmation through standard clinical methods. Additionally, many patients seek reassurance from healthcare professionals even after receiving positive at-home results, particularly when further care planning is needed.
As a result, the role of healthcare practitioners is evolving, according to Dr Sharma. Rather than acting solely as gatekeepers to testing, they are increasingly becoming interpreters and validators of patient-led diagnostics. According to Dr Sharma, GPs now focus more on guiding care, confirming results, and supporting patient decisions. To do this effectively, Dr Sharma states GPs must stay informed through continuous education, engagement with peers, and awareness of emerging diagnostic technologies and trends in healthcare.
Australian Health Journal also spoke with Michael Cima, CEO and Director of CC Supplies about the accessibility of consumer diagnostics and where women are able to choose how to test, have improved access and opt for privacy.
Source: Adapted from transcript
-
GP lens on Aboriginal health and COVID-19
The COVID-19 pandemic rolled through 2020 and the first half of 2021 without major lockdowns in regional communities, however recently that changed. The concern is now on vaccination rates in communities across Australia.
First Nation Aboriginal communities are at greater risk of outbreaks and transmission with low vaccination rates because of supply issues and changing advice rather than hesitancy.
-
Still seeking outcomes after 6th Stoma Appliance Scheme Schedule Review
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
